Indraprastha Medical Corporation LimitedINDRAMEDCOCorporate

Healthcare Latest results: Sep 2025 2 quarters of data

₹320.05

MCap ₹2,934 Cr

Indraprastha Medical Corporation Limited — Stock analysis & AI research Indraprastha Medical Corporation Limited — Seasonality — best & worst months Indraprastha Medical Corporation Limited — Technical indicators & charts Indraprastha Medical Corporation Limited — Technical setup — score, trend, support & resistance Indraprastha Medical Corporation Limited — Descending Channel pattern forming Indraprastha Medical Corporation Limited — Live exchange announcements

📋 High ROE Stocks 📋 High ROCE Stocks 📋 High Interest Coverage Stocks 📋 Stocks Cheaper Than Their Industry 📋 High Profit Growth Stocks 📋 GARP Stocks (PEG Below 1) 📈 New 52-Week Low Stocks 📈 Lowest Technical Score 📈 Multi-Timeframe Bearish Stocks 📈 Stocks Near 52-Week Low 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹381 Cr

Sales · Sep 2025

+8.9% YoY

₹71 Cr

Operating Profit · Sep 2025

+12.1% YoY

18.7%

OPM % · Sep 2025

+2.7% YoY

₹49 Cr

Net Profit · Sep 2025

+16.7% YoY

₹5.40

EPS · Sep 2025

+16.6% YoY

📝 Indraprastha Medical Corporation Limited — results explained

Quarter ended September 2025 (Q2 FY26)

Indraprastha Medical Corporation Limited reported revenue of ₹381 crore for the quarter ended September 2025 (Q2 FY26), up 8.9% from ₹350 crore in the same quarter last year.

Net profit rose 16.7% year-on-year to ₹49 crore, from ₹42 crore. Earnings per share (EPS) came in at ₹5.40.

Operating profit stood at ₹71 crore — an operating margin (OPM) of 18.7%, compared with 18.2% in the year-ago quarter.

Valuation snapshot

At the current price of ₹320.05, INDRAMEDCO has a market capitalisation of ₹2,934 crore.

Within the Healthcare industry, it is the 8th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 51.00%, foreign institutional investors (FIIs) 2.39%, domestic institutional investors (DIIs) 1.77%, public shareholders 44.84% of Indraprastha Medical Corporation Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹2,934 Cr

Current Price ?

₹320.1

P/E ?

N/A

Industry P/E ?

34.70

P/B ?

3.96

P/S ?

N/A

P/FCF ?

27.17

Enterprise Value ?

₹2,971 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

36.0%

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹381 Cr

PAT — latest qtr ?

₹49 Cr

YoY qtr sales growth ?

8.9%

YoY qtr profit growth ?

16.7%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹37 Cr

Debt to Equity ?

0.05

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

51.00%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-13.7%

Return 6 months ?

-25.1%

🗓️ Quarterly results (2 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Sep 2024	Sep 2025	YoY %	QoQ %
Sales	350	381	+8.9%	—
Operating Profit	64	71	+12.1%	—
Other Income	6	7	+21.8%	—
Interest	2	2	-5.0%	—
Depreciation	11	11	-2.8%	—
Profit Before Tax	57	66	+16.5%	—
Net Profit	42	49	+16.7%	—
EPS	4.63	5.40	+16.6%	—
OPM %	18.2%	18.7%	+2.7%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	92	92	92	92	+0.0%
Reserves	288	386	505	649	+28.5%
Borrowings	2	34	33	37	+12.1%
Other Liabilities	173	212	222	214	-3.6%
Total Liabilities	555	723	852	991	+16.3%
Fixed Assets	275	347	328	365	+11.3%
CWIP	3	0	33	3	-90.9%
Investments	-0	-0	-0	-0	—
Other Assets	278	376	491	624	+27.1%
Total Assets	555	723	852	991	+16.3%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	144	200	157	167	+6.4%
Cash from Investing Activity	-108	-158	-111	-178	-60.4%
Cash from Financing Activity	-26	-32	-46	-46	+0.0%
Net Cash Flow	11	9	-0	-57	—
Free Cash Flow	100	131	120	108	-10.0%
CFO/OP	102%	127%	89%	88%	-1.1%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	23	17	20	28	+40.0%
Inventory Days	—	—	—	11	—
Days Payable	—	—	—	182	—
Cash Conversion Cycle	23	17	20	-144	-820.0%
Working Capital Days	-12	-24	-19	-4	+78.9%
ROCE %	34%	38%	39%	36%	-7.7%

👥 Shareholding (latest 5 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Sep 2026	% Chg
Promoters	51.00%	51.00%	51.00%	51.00%	51.00%	+0.0%
FIIs	2.73%	2.41%	2.72%	2.43%	2.39%	-1.6%
DIIs	3.56%	3.51%	0.82%	0.87%	1.77%	+103.4%
Public	42.74%	43.08%	45.43%	45.69%	44.84%	-1.9%
No. of Shareholders	70,211	70,914	71,225	72,980	77,706	+6.5%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	VIJAYA Vijaya Diagnostic	₹1,507.80	15,530	82.7	857	187	42.3%	21.8%	19.5%	20.2%	22.8%	37.3%
2	METROPOLIS Metropolis Healthcare	₹596.30	12,370	61.1	1,710	203	24.7%	11.9%	23.6%	31.4%	16.6%	25.7%
3	HCG Healthcare Global	₹704.05	10,512	390.9	2,626	33	18.2%	1.3%	14.6%	-53.3%	13.1%	175.3%
4	YATHARTH Yatharth Hospital	₹988.90	9,528	54.1	1,200	171	23.6%	14.3%	36.2%	31.6%	47.6%	16.2%
5	JLHL Jupiter Life	₹277.85	9,109	9.7	1,557	187	22.1%	12.0%	20.9%	-6.7%	18.2%	-14.5%
6	THYROCARE Thyrocare Technologies	₹555.45	8,841	50.0	876	176	32.1%	20.1%	20.8%	79.4%	24.3%	33.2%
7	KOVAI Kovai Medical	₹6,260.50	6,850	26.7	1,644	256	27.9%	15.6%	15.7%	16.7%	15.3%	20.6%
8	INDRAMEDCO Indraprastha Medical	₹363.20	3,330	17.7	1,524	188	18.0%	12.4%	9.3%	13.7%	11.3%	9.5%
9	KRSNAA Krsnaa Diagnostics	₹543.40	1,763	18.1	816	98	26.8%	12.0%	7.8%	31.0%	22.1%	-19.3%
10	SURAKSHA Suraksha Diagnostic	₹311.85	1,624	45.3	325	35	31.4%	10.8%	23.1%	1.4%	20.7%	40.0%
11	SHALBY Shalby	₹132.15	1,418	38.0	1,176	37	12.1%	3.2%	5.0%	1683.0%	11.7%	36.7%
12	GPTHEALTH GPT Healthcare	₹157.90	1,296	27.4	491	48	18.5%	9.8%	15.1%	-21.9%	17.8%	62.5%
13	LAXMIDENTL Laxmi Dental	₹196.21	1,080	35.0	287	31	16.2%	10.9%	16.0%	-10.1%	13.2%	28.9%
14	NEPHROCARE Nephro Care	₹234.80	387	—	—	—	—	—	—	—	68.4%	347.7%
15	LOTUSEYE Lotus Eye	₹114.50	243	n/m	57	0	8.5%	0.3%	8.4%	-89.1%	26.2%	13.0%
16	UNIHEALTH Unihealth Hospitals	₹121.00	190	6.5	132	46	40.9%	34.8%	—	—	104.6%	71.5%
17	MADHAVBAUG Vaidya Sane	₹148.00	156	19.1	147	8	11.4%	5.6%	—	—	116.1%	94.3%
18	MHHL Mohini Health	₹57.05	104	—	145	-17	-1.4%	-11.7%	—	—	-6.6%	-1400.0%
19	MAITREYA Maitreya Medicare	₹120.65	82	—	45	-2	-1.0%	-5.5%	—	—	-5.2%	-1720.0%
20	AATMAJ Aatmaj Healthcare	₹26.75	60	83.6	24	1	9.7%	2.9%	—	—	22.5%	-39.4%
21	NIDAN Nidan Laborator.	₹33.00	46	30.6	26	2	19.0%	5.9%	—	—	-11.2%	-92.0%
22	ARTEMISMED Artemis Medicare	₹315.00	—	48.0	1,081	103	17.4%	9.6%	15.4%	25.9%	16.3%	30.9%

❓ Frequently asked questions

What was Indraprastha Medical Corporation Limited's revenue in Q2 FY26?